Neonatal General 2: Retinopathy of Prematurity / AI Data Analysis
Optimization of intravitreal Bevacizumab nanoparticles for the treatment of retinopathy of prematurity (ROP)
Saturday, April 26, 2025
1:00pm – 1:15pm HST
Location: Convention Center: Kalākaua Ballroom A (Level 4)
Suganesh Raghunathan, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States; Ben Amadi, University of Rochester, Rochester, NY, United States; Alfiya Raja, University of Rochester School of Medicine and Dentistry, Dublin, CA, United States; Olachi J. Mezu-Ndubuisi, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States
Presenting Author(s)
Olachi Mezu-Ndubuisi, MD, OD (she/her/hers)
Associate Professor with Tenure University of Rochester School of Medicine and Dentistry Rochester, New York, United States
Disclosure(s):
Olachi Mezu-Ndubuisi, MD, OD: I do not have any relevant financial / non-financial relationships with any proprietary interests.